
Healthcare Innovation: Building Smarter Systems for Medication Access
Alaa Salem is the founder and CEO of Metabolic Supply Group and a public health practitioner. After working in pharmacy ownership, he built a nationwide model connecting providers with compounding pharmacies, focused on affordability, medication transparency, and coordination across the supply chain. His experience includes helping grow a Florida compounding pharmacy that served about 30,000 patients in its first year. He later tested a lower-pricing model with 44 providers. That work shaped his focus on making patient savings part of business growth. In this episode… In this episode of Lessons from the Leap, host Ghazenfer Mansoor, CEO of Technology Rivers, known for AI, SaaS, and HIPAA-compliant HealthTech development, and author of Beyond the Download, sits down with Alaa Salem, founder and CEO of Metabolic Supply Group. Alaa left pharmacy ownership to build a nationwide network around a different premise: better pricing should benefit patients, too. Repeated negotiations with struggling clinics showed him that healthcare innovation needed to address affordability alongside quality and trust. Alaa explains how a pricing model tested with 44 providers became the starting point for that leap. He describes MSG Trace, which gives providers and patients access to batch-specific certificates of analysis, and AI applications for inventory planning, identifying product gaps, and preliminary clinical trial matching. The focus is practical: make medication sourcing easier to understand and coordinate without asking clinicians to manage every detail themselves. For founders and operators, the conversation connects healthcare innovation with the work required to scale it. Alaa shares why pharmacies, providers, testing labs, and delivery partners need to see value in the same model. From pharmacy liaisons who track documentation to hiring people who can work effectively with AI, the lesson is to build growth around clear responsibilities, shared incentives, and patient access.


















